Trimethoprim-sulfamethoxazole-induced aseptic meningitis

Journal of the National Medical Association

Volumn 97, Issue 12, 2005, Pages 1725-1728

  Wambulwa, Charles ^a,b   Bwayo, Salome ^a,c   Laiyemo, Adeyinka O ^a,c   Lombardo, Fredric ^a,c  

^a Howard University College of Medicine ^*

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c HOWARD UNIVERSITY HOSPITAL   (United States)

Author keywords

Adverse drug reaction; AIDS HIV; Aseptic meningitis; Trimethoprim sulfamethoxazole

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ALLOPURINOL; AMOXICILLIN; ASPARAGINASE; ATAZANAVIR; ATOVAQUONE; AZATHIOPRINE; CARBAMAZEPINE; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; CYTARABINE; DEXCHLORPHENIRAMINE; DICLOFENAC; GENTAMICIN; GRAMICIDIN; IBUPROFEN; IMMUNOGLOBULIN; INDINAVIR; INFLIXIMAB; IOTROLAN; LEVAMISOLE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; METRIZAMIDE; METRONIDAZOLE; MONOCLONAL ANTIBODY CD3; NONSTEROID ANTIINFLAMMATORY AGENT; OKT 3; UNINDEXED DRUG; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; ANTIBIOTIC PROPHYLAXIS; ASEPTIC MENINGITIS; BACTERIAL MENINGITIS; DRUG SURVEILLANCE PROGRAM; HUMAN; LISTERIA MONOCYTOGENES; LISTERIOSIS; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-INFECTIVE AGENTS; HUMANS; MALE; MENINGITIS, ASEPTIC; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS; RISK FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 28744441608     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Chaudhry HJ, Cunha BA. Drug-induced aseptic meningitis. Diagnosis leads to quick resolution. Postgrad Med. 1991;90(7):65-70.
2. Dalton M, Newton RW. Aseptic meningitis. Dev Med Child Neurol. 1991; 33(5):446-451.
3. Moris G, Garcia-Monco J. The challenge of drug-induced aseptic meningitis. Arch Intern Med. 1999;159(11):1185-1194.
4. Antonen J, Hulkkonen J, Pasternack A, et al. Interleukin-6 may be an important mediator of Trimethoprim-induced systemic adverse reaction resembling aseptic meningitis. Arch Intern Med. 2000;160:2066-2067.
5. Robbins, SL, Cotran RS, Kumar V, et al. Acute and Chronic inflammation. In: Robbins, SL, Cotran RS, Kumar V, et al. Pathologic Basis of Disease. 6th ed. Philadelphia: W.B. Sounders, 1999:73-74.
6. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87: 2095-2147.
7. Beutler B. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med. 1995;43(3):227-235.
8. Floris-Moore MA, Amodio-Groton MI, Catalano MT. Adverse effects to TMP/Sulfamethaxazole. Ann Pharmacother. 2003;37(12):1810-1813.
9. Koirala J. Trimethoprim-sulfamethoxazole-induced methemoglobinemia in an HIV-infected patient. Mayo Clin Proc. 2004;79(6):829-830.
10. Jurado R, Carpenter SL, Rimland D. Trimethoprim-Sulfamethoxazole-Induced Meningitis in Patients with HIV Infection. Am J Med Sci. 1996;312(1):27-29.
11. Harrison MS, Simonte SJ, Kauffman CA. Trimethoprim-induced aseptic meningitis in a patient with AIDS: case report and review. Clin infect Dis. 1994;19(3):431-434.
12. Bouvier F, Lafaix C. A rare case of cotrimoxazole-induced eosinophilic aseptic meningitis in an HIV-infected patient. Scand J infect Dis. 1998; 30(5):530-531.
13. Muller MP, Richardson DC, Walmsley SL. Trimethoprim-sulfamethoxazole induced aseptic meningitis in a renal transplant patient. Clin Nephrol. 2001;55(1):80-84.
14. Escalante A, Stimmler MM. Trimethoprim-sulfamethoxasole induced meningitis in systemic lupus erythematosus. J Rheumatol. 1992;19(5):800-802.
15. De la Monte SM, Hutchins GM, Gupta PK. Aseptic meningitis, trimethoprim, and Sjogren's syndrome. JAMA. 1985 19;253(15):2192.
16. Therrien R. Possible Trimethoprim/Sulfamethoxazole-induced aseptic meningitis. Ann Pharmacother. 2004;38(11):1863-1867.
17. Trepanier LA, Danhof R, Toll J, et al. Clinical findings in 40 dogs with hypersensitivity associated with administration of potentiated sulfonamides. Journal of Veterinarian Internal Medicine. 2003;17:647-652.
18. Carlson J, Wiholm BE. Trimethoprim associated aseptic meningitis. Scand J Infect Dis. 1987;19(6):687-691.
19. Redman RC IV, Miller JB, Hood M, et al. Trimethoprim-induced aseptic meningitis in an adolescent male. Pediatrics. 2002;110(2 Pt 1):e26.
20. Gilroy N, Gottlieb T, Spring P, et al. Trimethoprim-induced aseptic meningitis and uveitis. Lancet. 1997;350(9071):112.
21. Saag MS. Cryptococcosis and other fungal infections (Histoplasmosis, Coccidiomycosis). In: The medical management of AIDS. Sande MA, Volberding PA, eds. 6th ed. Philadelphia: W.B. Sounders, 1999;361-370.
22. Worthington MG, Ross JJ. HAART Interruption & Acute HIV Syndrome: aseptic meningitis and acute HIV syndrome after interruption of antiretroviral therapy: implications for structured treatment interruptions. AIDS. 2003; 17(14):2145-2146 (Correspondence).
23. Gilbert DN, Moellering RC, Eliopoulos GM, et al. Clinical approach to initial choice of antimicrobial therapy. In: The Sanford Guide to Antimicrobial Therapy. 35th ed. VT: Antimicrobial Therapy Inc., 2005;29.
24. Rudy BJ, Rutstein R. Aseptic meningitis from trimethoprim- sulfamethoxazole in an HIV infected adolescent. Pediatric Emerg Care. 1997;13(3):216-217.
25. Wong JG, Hathaway SC, Paat JJ, et al. Drug-induced meningitis. A case involving trimethoprim-sulfamethoxazole. Postgrad Med. 1994;96(6): 117-118,121,124.
26. Gordon MF, Allon M, Coyle PK. Drug-induced meningitis. Neurology. 1990;40(1):163-164.
27. Tunkel AR, Starr K. Trimethoprim-sulfamethoxazole-associated aseptic meningitis. Am J Med. 1990;88(6):696-697.
28. Joffe AM, Farley JD, Linden D, et al. Trimethoprim-sulfamethoxazole- associated aseptic meningitis: case reports and review of the literature. Am J Med. 1989;87(3):332-338.
29. Hopkins S, Jolles S. Drug-induced aseptic meningitis. Expert opinion. Drug Saf. 2005;4(2):285-297.
30. Slavik RS, Rybak MJ, Lerner SA. Trimethoprim/sulfamethoxazole induced tremor in a patient with AIDS. Ann Pharmacother. 1998;32(2):189-192.
31. Patterson RG, Couchenour RL. Trimethoprim-sulfamethoxazole-induced tremor in immunocompetent patients. Pharmacotherapy. 1999;19(12): 1456-1458.